Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02191488 · ClinicalTrials.gov registry record · Phase 1
ALA-induced PpIX Fluorescence During Brain Tumor Resection
A Phase 1 study of Brain Tumors, sponsored by David W. Roberts.
- Active
- Registry status
- Phase 1
- Development phase
- 540
- Enrollment target
- 1
- Study location
NCT02191488 is a Phase 1 study of Brain Tumors that is active but no longer recruiting, run by David W. Roberts. The registered enrollment target is 540 participants, below the 6,289-participant average among 10 other Brain Tumors trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02191488, a Phase 1 study of Brain Tumors, is active but no longer recruiting, sponsored by David W. Roberts.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 540 participants
- Enrollment target
- 1
- Study location
Study Summary
Removing a tumor from a patients brain is hard to do because, very often, brain tumors do not have boundaries that are easy for the patients surgeon to find. In many cases, the surgeon can't tell exactly where the tumor begins or ends. The surgeon usually can remove most of the patient's tumor by looking at the MRI images that were taken of the patient's brain before surgery. However, the surgeon does not have any good way to tell if the entire tumor has been removed or not. Removing the entire tumor is very important because leaving tumor behind may allow it to grow back which could decrease the chances of survival.
Conditions Studied
Interventions
- DRUG 5-aminolevulinic acid
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2014-07 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02191488
The ClinicalTrials.gov registry entry for NCT02191488 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,289-participant average among 10 other Brain Tumors trials with a reported enrollment target (91% lower). The listed sponsor is David W. Roberts, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Tumors appearing as the primary indexed condition, and to 1 intervention - of which 5-aminolevulinic acid is the first listed.
NCT02191488 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT02191488 about?
NCT02191488 is a clinical study titled "ALA-induced PpIX Fluorescence During Brain Tumor Resection". Removing a tumor from a patients brain is hard to do because, very often, brain tumors do not have boundaries that are easy for the patients surgeon to find. In many cases, the surgeon can't tell exactly where the tumor begins or ends. The surgeon usually can remove most of the patient's tumor by lo...
What is the current status of trial NCT02191488?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 540 participants. The study started on 2014-07. Estimated completion is 2026-12-31.
What conditions does trial NCT02191488 study?
This clinical trial studies the following conditions: Brain Tumors.
What interventions are being tested in trial NCT02191488?
The interventions under investigation include: 5-aminolevulinic acid (DRUG).
Who is sponsoring clinical trial NCT02191488?
This trial is sponsored by David W. Roberts, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02191488 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
COMPLETED · Phase 1
-
Nicardipine vs Esmolol Craniotomy Emergence
COMPLETED · Phase 1
-
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
COMPLETED · Phase 1
-
Florida Center for Brain Tumor Research
RECRUITING
-
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
ACTIVE NOT RECRUITING
-
Blood Flow MRI for Monitoring Brain Tumors
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.